Divergent Androgen Receptor and Beta-Catenin Signaling in Prostate Cancer Cells

Despite decades of effort to develop effective therapy and to identify promising new drugs, prostate cancer is lethal once it progresses to castration-resistant disease. Studies show mis-regulation of multiple pathways in castration-resistant prostate cancer (CRPC), reflecting the heterogeneity of t...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Eugine, Ha, Susan, Logan, Susan K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4624871/
https://www.ncbi.nlm.nih.gov/pubmed/26509262
http://dx.doi.org/10.1371/journal.pone.0141589

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4624871/
https://www.ncbi.nlm.nih.gov/pubmed/26509262
http://dx.doi.org/10.1371/journal.pone.0141589

Ejemplares similares